Thermo Fisher Scientific Inc.
TMO | NYSE
$685.67
-$11.33 (-1.63%)
Nov 2, 2026, 12:41 PM ET · Market open
TTM Period Ending | Q3 2026 Sep 26, 2026 | Q2 2026 Jun 27, 2026 | Q1 2026 Mar 28, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 27, 2025 | Q2 2025 Jun 28, 2025 | Q1 2025 Mar 29, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 28, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jul 1, 2023 | Q1 2023 Apr 1, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Oct 1, 2022 | Q2 2022 Jul 2, 2022 | Q1 2022 Apr 2, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Oct 2, 2021 | Q2 2021 Jul 3, 2021 | Q1 2021 Apr 3, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 47.35B | 46.34B | 45.2B | 44.56B | 43.74B | 43.21B | 42.9B | 42.88B | 42.37B | 42.35B | 42.49B | 42.86B | 43.42B | 43.52B | 43.81B | 44.92B | 44.17B | 42.82B | 41.12B | 39.21B | 39.06B | 38.25B | 35.89B |
Cost of Revenue | 27.73B | 27.32B | 26.72B | 26.31B | 26.03B | 25.75B | 25.5B | 25.51B | 25.51B | 25.5B | 25.72B | 26.12B | 26.48B | 26.59B | 26.56B | 26.37B | 24.85B | 23.18B | 21.53B | 19.9B | 19.39B | 18.89B | 17.69B |
Gross Profit | 19.62B | 19.01B | 18.48B | 18.25B | 17.7B | 17.46B | 17.4B | 17.37B | 16.86B | 16.85B | 16.77B | 16.74B | 16.94B | 16.93B | 17.25B | 18.55B | 19.32B | 19.64B | 19.59B | 19.31B | 19.67B | 19.36B | 18.21B |
Operating Income | 8.52B | 8.33B | 8.16B | 8.13B | 8.1B | 7.94B | 7.78B | 7.66B | 7.39B | 7.44B | 7.47B | 7.45B | 7.44B | 7.23B | 7.39B | 8.53B | 9.22B | 9.81B | 10.12B | 10.35B | 10.81B | 10.85B | 10.05B |
Interest Income | 950M | 932M | 1.02B | 992M | 961M | 1B | 1B | 1.08B | 1.16B | 1.13B | 1.01B | 879M | 720M | 542M | 400M | 272M | 133M | 74M | 49M | 43M | 44M | 44M | 41M |
Pretax Income | 7.87B | 7.61B | 7.4B | 7.27B | 7.12B | 7.02B | 6.99B | 7B | 6.76B | 6.78B | 6.51B | 6.24B | 6.25B | 6.03B | 6.48B | 7.66B | 7.78B | 8.42B | 8.6B | 8.83B | 9.87B | 9.95B | 9.15B |
Net Income | 7.08B | 6.98B | 6.86B | 6.72B | 6.57B | 6.58B | 6.52B | 6.34B | 6.14B | 6.22B | 6.03B | 6B | 5.94B | 5.72B | 6.02B | 6.95B | 7.03B | 7.44B | 7.6B | 7.73B | 8.57B | 8.6B | 7.92B |
Selling & General & Admin | 7.92B | 8.22B | 8.45B | 8.73B | 8.21B | 8.12B | 8.23B | 8.32B | 8.13B | 8.09B | 7.98B | 7.95B | 8.1B | 8.27B | 8.41B | 8.55B | 8.63B | 8.36B | 8.02B | 7.56B | 7.47B | 7.17B | 6.9B |
Research & Development | 1.41B | 1.4B | 1.39B | 1.4B | 1.42B | 1.41B | 1.4B | 1.39B | 1.34B | 1.32B | 1.32B | 1.34B | 1.4B | 1.43B | 1.45B | 1.47B | 1.47B | 1.47B | 1.45B | 1.41B | 1.39B | 1.34B | 1.26B |
Other Expenses | 1.78B | 1.06B | 479M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 11.11B | 10.69B | 10.32B | 10.13B | 9.62B | 9.54B | 9.63B | 9.71B | 9.47B | 9.4B | 9.31B | 9.29B | 9.5B | 9.7B | 9.86B | 10.02B | 10.1B | 9.83B | 9.47B | 8.96B | 8.86B | 8.51B | 8.16B |
Interest Expense | 1.54B | 1.47B | 1.47B | 1.42B | 1.44B | 1.52B | 1.53B | 1.59B | 1.65B | 1.62B | 1.53B | 1.46B | 1.29B | 1.07B | 890M | 726M | 618M | 573M | 547M | 536M | 521M | 537M | 552M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 38.84B | 38.01B | 37.04B | 36.42B | 35.64B | 35.27B | 35.12B | 35.22B | 34.99B | 34.9B | 35.03B | 35.41B | 35.98B | 36.3B | 36.42B | 36.39B | 34.95B | 33.01B | 31B | 28.86B | 28.25B | 27.4B | 25.85B |
Income Tax Expense | 742M | 597M | 522M | 547M | 544M | 436M | 472M | 658M | 641M | 595M | 519M | 284M | 324M | 302M | 448M | 703M | 732M | 972M | 993M | 1.11B | 1.3B | 1.35B | 1.23B |
Shares Outstanding (Basic) | 370M | 371M | 372M | 376M | 378M | 378M | 378M | 382.85M | 382M | 382M | 382M | 387M | 386M | 386M | 386M | 391M | 392M | 392M | 392M | 394M | 394M | 393M | 394M |
Shares Outstanding (Diluted) | 371M | 371M | 373M | 377M | 378M | 378M | 379M | 383M | 384M | 383M | 384M | 388M | 388M | 388M | 388M | 393M | 395M | 394M | 395M | 398M | 397M | 396M | 397M |
EPS (Basic) | 18.99 | 18.62 | 18.22 | 17.77 | 17.34 | 17.33 | 17.10 | 16.59 | 16.01 | 16.18 | 15.66 | 15.52 | 15.34 | 14.71 | 15.42 | 17.73 | 17.90 | 18.92 | 19.33 | 19.61 | 21.71 | 21.76 | 20.03 |
EPS (Diluted) | 18.96 | 18.59 | 18.19 | 17.74 | 17.31 | 17.28 | 17.04 | 16.52 | 15.94 | 16.12 | 15.59 | 15.45 | 15.26 | 14.62 | 15.33 | 17.62 | 17.78 | 18.79 | 19.18 | 19.45 | 21.52 | 21.57 | 19.86 |
EBITDA | 11.24B | 11.57B | 11.46B | 11.48B | 11.33B | 11.4B | 11.58B | 11.74B | 11.69B | 11.8B | 11.43B | 11.17B | 11.04B | 10.64B | 10.93B | 11.94B | 11.75B | 12.07B | 12B | 11.96B | 12.9B | 12.94B | 12.08B |
EBIT | 8.96B | 8.63B | 8.65B | 8.7B | 8.54B | 8.53B | 8.6B | 8.63B | 8.49B | 8.48B | 8.05B | 7.76B | 7.62B | 7.24B | 7.55B | 8.56B | 8.54B | 9.07B | 9.17B | 9.37B | 10.39B | 10.48B | 9.7B |
Depreciation & Amortization | 2.28B | 2.94B | 2.81B | 2.78B | 2.79B | 2.87B | 2.98B | 3.11B | 3.21B | 3.32B | 3.38B | 3.41B | 3.42B | 3.4B | 3.38B | 3.38B | 3.22B | 3.01B | 2.83B | 2.59B | 2.51B | 2.46B | 2.37B |
Add to Watchlist
Select watchlists to add or remove TMO